Raloxifene Use for The Heart

PHASE3CompletedINTERVENTIONAL
Enrollment

10,000

Participants

Timeline

Start Date

June 30, 1998

Study Completion Date

November 30, 2005

Conditions
Cardiovascular DiseasesBreast Neoplasms
Interventions
DRUG

raloxifene

DRUG

placebo

Trial Locations (1)

Unknown

For additonal information regarding investigative sites for this trial, please call 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Monday-Friday, 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician, Minneapolis

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00190593 - Raloxifene Use for The Heart | Biotech Hunter | Biotech Hunter